Prosonix Appoints New Scientific Advisory Board
Prosonix announced the appointment of a new Scientific Advisory Board. The new SAB comprises internationally renowned scientific, regulatory and clinical advisors who will act as both key collaborators and advocates for the business in the global pharmaceutical arena.
- Professor Peter Barnes: Professor Barnes is Professor of Thoracic Medicine and Head of Airway Disease at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London. He is amongst the top 50 most highly cited researchers in the world and has been the most highly cited clinical scientist in the UK and the most highly cited respiratory researcher in the world over the past 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He is currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest and respiratory Editor of PLoS Medicine.
- Dr Marianne Mann: Dr Mann is a board-certified pulmonologist and independent consultant specialising in regulatory and clinical drug development, with specific interest in respiratory diseases. She worked at the US Food and Drug Administration (FDA) for nine years, between 1994 and 2003, the last three of which were as Deputy Director of the Division of Pulmonary and Allergy Drug Products.
- Dr John Pritchard: Dr Pritchard is Chief Technology Officer at Philips' Respironics drug delivery unit. In this role, he is responsible for global R&D activities in respiratory drug delivery, focusing on next-generation adaptive aerosol delivery technology. Dr Pritchard has over 30 years of experience in the aerosol and respiratory field, including experience at AstraZeneca as head of respiratory project management. He has also worked for 3M Healthcare and GlaxoSmithKline.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

BASF acquires global leader in omega-3 fatty acids
Finger-trap tension stabilizes cells' chromosome-separating machinery - Accurate gene distribution during cell division depends on stable set-up

New research sheds light on neuronal communication
List_of_subjects_in_Gray's_Anatomy:_III._Syndesmology
Children's ability to detect sugar varies widely
Egg meets sperm: The female side of the story
Teva announces successful results of Phase III with oral laquinimod for multiple sclerosis
Molecule determines friendships
AI driven biopharmaceutical startup raises $10M in series A financing

Single-cell technology: Targeted printing - Bright prospects for personalized medicine
